Double combination therapy in patients with pulmonary arterial hypertension associated with connective tissue disease

E. Gotti, E. Leci, A. Manes, M. Palazzini, E. Beciani, E. Conficoni, N. Rizzo, F. Terzi, G. Mazzanti, F. Sciarra, N. Galiè (Bologna, Italy)

Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Session: Treatment of human pulmonary hypertension
Session type: Thematic Poster Session
Number: 2298
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Gotti, E. Leci, A. Manes, M. Palazzini, E. Beciani, E. Conficoni, N. Rizzo, F. Terzi, G. Mazzanti, F. Sciarra, N. Galiè (Bologna, Italy). Double combination therapy in patients with pulmonary arterial hypertension associated with connective tissue disease. Eur Respir J 2011; 38: Suppl. 55, 2298

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Source: Eur Respir J, 50 (2) 1602493; 10.1183/13993003.02493-2016
Year: 2017



Double combination therapy in patients with pulmonary arterial hypertension associated with congenital heart defects
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

Pulmonary arterial hypertension in connective tissue diseases
Source: Eur Respir Mon 2012; 57: 42-57
Year: 2012


Pulmonary arterial hypertension associated with connective tissue disease: an integrated approach
Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience
Year: 2008

Veno-occlussive lesions and inflammation in pulmonary arterial hypertension associated with connective tissue diseases
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
Source: Eur Respir Rev 2014; 23: 505-509
Year: 2014


Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Autoantibodies are frequently found in arterial and chronic thrombotic pulmonary hypertension not associated to connective tissue diseases
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012

Oxygen pulse slope analysis during exercise testing identifies patients with systemic sclerosis at a possible risk for developing pulmonary vasculopathy
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013

Identifying early pulmonary arterial hypertension in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018
Year: 2018



The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008


Bosentan for sarcoidosis associated pulmonary arterial hypertension (BoSAPH) was effective in advanced parenchymal lung disease
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012



Response to PAH specific therapy in systemic sclerosis patients with extensive parenchymal changes and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment
Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020
Year: 2021



Refining definitions of time to clinical worsening in connective tissue disease-associated pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients
Source: Eur Respir J 2014; 44: 963-972
Year: 2014